What is BCTX's current stock price?

As of now, BCTX is trading at $4.93, with a daily change of -54.90%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

BCTX Stock Analysis & IQ Rating | BriaCell Therapeutic

BCTX

BriaCell Therapeutic

$4.93

-$5.99 | -54.90%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$98.1

MKT CAP

$13.09M

52W Low

$4.75

VOL

$4.28M

P/E Ratio

N/A

AVG VOL

$318.69K

RSI

37.35

TREND

Sideways

BCTX Stock IQ

Login to see BriaCell Therapeutic (BCTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

BCTX Target Price

Login to display

Not Enough Information

BCTX Price Performance

$8.98 (-45.10%)

$11.72 (-57.94%)

$0.72 (+584.72%)

$0.37 (+1232.43%)

1year

6month

3month

1month

BCTX Risk Level

BCTX has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Low volume

High volatilty

Extreme

LOW

HIGH

BCTX Analysts Opinion

BCTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

BCTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

75%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

33%

NA

BCTX Performance Sentiment

Sentiments overview associated with BCTX events and the stock performance.

75%

25%

Positive

Negative

6 out of 8
events present

2 out of 8
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Explore our BCTX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored BCTX Stock Strategies
Effective Risk Management

FIND US ON

Receive our BCTX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

BCTX

BriaCell Therapeutic

Set Alerts

Current Price

$4.93

-$5.99 | -54.90%

52W High

$98.1

MKT CAP

$13.09M

52W Low

$4.75

VOL

$4.28M

P/E Ratio

N/A

AVG VOL

$318.69K

RSI

37.35

TREND

Sideways

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

BCTX Stock IQ

Login to unlock BriaCell Therapeutic (BCTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Not Enough Information

BCTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

75%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

33%

NA

BCTX Risk Level

BCTX has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Low volume

High volatilty

Extreme

LOW

HIGH

BCTX Performance Sentiment

Sentiments overview associated with BCTX events and the stock performance.

75%

25%

Positive

Negative

6 out of 8
events present

2 out of 8
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

BCTX Latest Analysis

BriaCell Plunges On Pricing Announcement Of $30Mln Public Offering . (RTTNews) - BriaCell Therapeutics Corp. (BCTX BCTXL) a clinical-stage biotechnology company on Wednesday announced the pricing of a public offering of 5.367 million units at $5.59 per unit for gross proceeds of approximately $30 million.

Today

$4.93 | -54.90%

Activity

Momentum

Whats Going On With BriaCell Therapeutics Stock Wednesday?. ) stock plunged on Wednesday after rallying on Tuesday on positive data from a breast cancer trial.This small biotechnology company focused on cancer has a market capitalization of approximately $20.57 million according to .During after-hours trading on Tuesday BriaCell Therapeutics priced its .The clinical-stage biotechnology company focused on cancer immunotherapies priced 5.37 million units at $5.59 per unit.Each unit consists of one

Today

$4.93 | -54.90%

Activity

Momentum

BriaCell Therapeutics Announces Pricing of $30 million Public Offering. BCTXL)) (TSX:) (BriaCell or the Company) a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care today announced the pricing of a best-efforts public offering of 5366726 units. Each unit consists of one common share (or pre-funded warrant (Pre-Funded Warrant) in lieu thereof) and one warrant (the Warrants). Each unit is being sold to the public at a price of $5.59 per unit (inclus

Today

$4.93 | -54.90%

Activity

Discover BCTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of BCTX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our BCTX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

BCTX Stock trends

BCTX Stock performance

BCTX Stock analysis

BCTX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing BCTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing BCTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

BCTX Stock Analysis & IQ Rating | BriaCell Therapeutic

BCTX Stock IQ

BCTX Target Price

BCTX Risk Level

BCTX Analysts Opinion

BCTX Street Sentiment

BCTX Performance Sentiment

Explore our BCTX Stock insights

Receive our BCTX Daily Alerts

BCTX Street Sentiment

BCTX Risk Level

Discover BCTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of BCTX. We're here to help you make informed investment decisions today.

Receive our BCTX Daily Alerts

BCTX Alerts